Pharmalab Polandsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-12-06
Share capital
100,000.00 PLN
Registered address
ul. Siemianowicka 84, 41-902 Bytom, Poland
Electronic delivery address
AE:PL-73009-14093-BEFDV-28

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

1 of 2 financial statements was filed late (for 2025, 55 days late).

  • 202508/09/2026
  • 202415/07/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of pharmaceutical preparations181 / 184
Top 98%
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations228 / 231
Top 99%
Sector · Manufacturing24,051 / 24,467
Top 98%
City · Bytom707 / 722
Top 98%
Voivodeship · Śląskie32,442 / 33,281
Top 97%
Country · Poland288,755 / 297,932
Top 97%

Results vs industry

Revenue
This companyUSD 4.05MedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -71.82kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 75.76kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 1.46mMedianUSD 897.46kAverageUSD 31.52m

Industry

Trademarks

Pharmalab Poland holds 24 active trademarks registered with the Polish Patent Office. 1 application is pending. 10 marks have expired or were not registered. The first mark was filed in 2024.

MarkNumberClassesStatusProtected until
DESLORIN(word)Z.5880095Protected Jul 25, 2035
DORNASEN(word)Z.5880185Protected Jul 25, 2035
DORSEMINA(word)Z.5880175Protected Jul 25, 2035
CIROXIL(word)Z.5880165Protected Jul 25, 2035
CINAPROX(word)Z.5880145Protected Jul 25, 2035
MarkProtected until
DESLORIN(word)Jul 25, 2035
DORNASEN(word)Jul 25, 2035
DORSEMINA(word)Jul 25, 2035
CIROXIL(word)Jul 25, 2035
CINAPROX(word)Jul 25, 2035

Authorized Representatives

Bartosz Olszewskiage 41 – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Bartosz Olszewskiage 41
1,000$27,012.43100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2023-12-22.

  • mBank
    mBank
    55 1140 1078 0000 3191 7400 1001
  • mBank
    mBank
    98 1140 1078 0000 3191 7400 1003
  • mBank
    mBank
    71 1140 1078 0000 3191 7400 1004

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
STEM Cells SpinS.A.
F1 PharmaS.A.
Ti-Comsp. z o.o.
LideoS.A.
Munar PharmaS.A.
BIO Animalisp. z o.o.
Ampliconsp. z o.o.
Xenira Pharmaceuticalssp. z o.o.
Sanford Biotechsp. z o.o.
Cefeasp. z o.o.

FAQ

Last updated: 2026-10-07